Chinese COVID-19 vaccines enters Phase III clinical trials in Turkey
Chinese COVID-19 vaccines enters Phase III clinical trials in Turkey
Chinese COVID-19 vaccines enters Phase III clinical trials in Turkey. On November 23, 2020, China Daily reported that the COVID-19 vaccine “CoronaVac” (CoronaVac) developed by China Kexing Biotech officially entered the phase III clinical trial phase in Ankara, Turkey.
Preliminary test results last week showed that the vaccine can quickly induce an immune response, although the antibodies produced are less than the number of antibodies detected in patients recovering from the COVID-19.
According to the researchers, based on past experience, “Kierlai Fu” can provide adequate protection. On the 19th, 120,000 doses of the vaccine arrived in Brazil from China.
Previous Report about Chinese COVID-19 vaccines in Turkey
The Turkish Ministry of Health stated that the Phase III clinical trial of China’s new coronavirus vaccine was launched in Turkey.
On September 16, Turkey’s Minister of Health, Fahrettin Koca, said at a press conference: “The Phase III clinical trial of the Chinese vaccine has been launched in Turkey.” “The first Chinese vaccine was from Hacettepe University (Hacettepe University). ), they volunteered to participate in the trial.”
The report quoted CNN Turkish Channel and Turkish local media “Haberturk” as saying that 1,200-1300 medical staff will be vaccinated twice in the phase 3 clinical trial, with an interval of 14 days.
